Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Wooster

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Molecular Cancer Therapeutics|June 6, 2020
Novel Miniaturized Drug Conjugate Leverages HSP90-driven Tumor Accumulation to Overcome PI3K Inhibitor Delivery Challenges to Solid TumorsSamantha Perino, Benoit Moreau, Jessica Freda, et al.
Cancer Research|March 18, 2010
Serial transcriptome analysis and cross-species integration identifies centromere-associated protein E as a novel neuroblastoma targetNaomi J Balamuth, Andrew Wood, Qun Wang, et al.
Genome Research|February 6, 2004
High-resolution analysis of DNA copy number using oligonucleotide microarraysGraham R Bignell, Jing Huang, Joel Greshock, et al.
Molecular Cancer Therapeutics|June 24, 2010
Sensitivity of cancer cells to Plk1 inhibitor GSK461364A is associated with loss of p53 function and chromosome instabilityYan Degenhardt, Joel Greshock, Sylvie Laquerre, et al.
Cancer Research|November 20, 2002
Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasiaSiu T Yuen, Helen Davies, Tsun L Chan, et al.
Oncogene|January 13, 2004
Amplification and overexpression of E2F3 in human bladder cancerAndrew Feber, Jeremy Clark, Graham Goodwin, et al.
Genomics|January 13, 2006
High throughput DNA sequence variant detection by conformation sensitive capillary electrophoresis and automated peak comparisonHelen Davies, Ed Dicks, Philip Stephens, et al.
Cancer Research|October 8, 2009
Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinasesFawn Qian, Stefan Engst, Kyoko Yamaguchi, et al.
Journal of Medicinal Chemistry|February 9, 2019
Discovery of an SSTR2-Targeting Maytansinoid Conjugate (PEN-221) with Potent Activity in Vitro and in VivoBrian H White, Kerry Whalen, Kristina Kriksciukaite, et al.
Cancer Research|December 4, 2002
BRAF and RAS mutations in human lung cancer and melanomaMarcia S Brose, Patricia Volpe, Michael Feldman, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Molecular Cancer Therapeutics|June 6, 2020
Novel Miniaturized Drug Conjugate Leverages HSP90-driven Tumor Accumulation to Overcome PI3K Inhibitor Delivery Challenges to Solid TumorsSamantha Perino, Benoit Moreau, Jessica Freda, et al.
Cancer Research|March 18, 2010
Serial transcriptome analysis and cross-species integration identifies centromere-associated protein E as a novel neuroblastoma targetNaomi J Balamuth, Andrew Wood, Qun Wang, et al.
Genome Research|February 6, 2004
High-resolution analysis of DNA copy number using oligonucleotide microarraysGraham R Bignell, Jing Huang, Joel Greshock, et al.
Molecular Cancer Therapeutics|June 24, 2010
Sensitivity of cancer cells to Plk1 inhibitor GSK461364A is associated with loss of p53 function and chromosome instabilityYan Degenhardt, Joel Greshock, Sylvie Laquerre, et al.
Cancer Research|November 20, 2002
Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasiaSiu T Yuen, Helen Davies, Tsun L Chan, et al.
Oncogene|January 13, 2004
Amplification and overexpression of E2F3 in human bladder cancerAndrew Feber, Jeremy Clark, Graham Goodwin, et al.
Genomics|January 13, 2006
High throughput DNA sequence variant detection by conformation sensitive capillary electrophoresis and automated peak comparisonHelen Davies, Ed Dicks, Philip Stephens, et al.
Cancer Research|October 8, 2009
Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinasesFawn Qian, Stefan Engst, Kyoko Yamaguchi, et al.
Journal of Medicinal Chemistry|February 9, 2019
Discovery of an SSTR2-Targeting Maytansinoid Conjugate (PEN-221) with Potent Activity in Vitro and in VivoBrian H White, Kerry Whalen, Kristina Kriksciukaite, et al.
Cancer Research|December 4, 2002
BRAF and RAS mutations in human lung cancer and melanomaMarcia S Brose, Patricia Volpe, Michael Feldman, et al.
Pageof 7